Utilizing multimodal mass spectrometry imaging for profiling immune cell composition and N-glycosylation across colorectal carcinoma disease progression is a research paper published in Frontiers in Pharmacology (2024). On theSindex it has a DataRank of 0.416. It has been cited 15 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.416
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NIGMS NIH HHS
Grant: P20 GM130457
NCI NIH HHS
Grant: R01 CA226086
NCATS NIH HHS
Grant: UL1 TR001450
NIDDK NIH HHS
Grant: P30 DK123704
NIDDK NIH HHS
Grant: T32 DK124191
NCI NIH HHS
Grant: R33 CA267226
NCI NIH HHS
Grant: U54 CA210962
NCI NIH HHS
Grant: T32 CA193201
NCATS NIH HHS
Grant: UL1 TR000062
NCI NIH HHS
Grant: P30 CA138313
NLM NIH HHS
Grant: R01 LM012517
NCI NIH HHS
Grant: U01 CA242096
FWCI
2.42
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals